PO.TB05.01 · 肿瘤生物学

多组学分析揭示转移性骨肉瘤中的内皮细胞可塑性

Multiomic profiling reveals endothelial cell plasticity in metastatic osteosarcoma

海报缩略图:多组学分析揭示转移性骨肉瘤中的内皮细胞可塑性
编号 640 展板 19 时间 4/19 02:00–05:00 区域 Section 26 主讲 Troy McEachron, PhD
分会场 Developmental Origins, Drivers, and Heterogeneity in Pediatric Cancer
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Ying Wu, Julian Burks, Demond Williams, Carly Sayers, Vidhur Daulatabad, Neeraja Syed, John F. Shern, Troy A. McEachron

Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD

摘要 Abstract

中文摘要
转移性骨肉瘤是一种侵袭性恶性骨肿瘤,主要影响儿童、青少年和年轻成人群体,是一种研究不足且存在重大未满足医疗需求的疾病。近期研究越来越聚焦于理解骨肉瘤微环境的复杂生物学。虽然既往研究主要考察了巨噬细胞、淋巴细胞以及在较小程度上成纤维细胞的作用,但肿瘤脉管系统受到的关注相对较少。 为填补这一关键空白,我们对24例人转移性骨肉瘤标本队列进行了单核多组学(RNA+ATAC)测序。我们的数据显示,转移微环境中的内皮细胞采用了一种提示内皮-间质转化(EndMT)的杂合转录状态。利用我们的多模态数据集,联合拷贝数分析识别出一部分与内皮细胞聚类在一起的肿瘤细胞,表明骨肉瘤细胞参与了血管拟态。对基因调控网络的进一步研究揭示了一部分正在经历内皮-成骨转化的内皮细胞,并证实了骨肉瘤血管拟态细胞中内皮特异性调控程序的存在。对免疫抑制基因表达的分析提示,转移性骨肉瘤中的内皮细胞还发挥免疫调节功能。 采用体外和体内功能实验来验证这些发现。改良的transwell共培养实验表明,骨肉瘤来源的因子可在肺微血管内皮细胞中诱导成骨基因表达程序。此外,通过将内皮谱系示踪小鼠与GFP+同基因小鼠骨肉瘤细胞相结合,我们提供了体内证据,证明内皮细胞可被重编程为成骨样细胞并整合入恶性骨样组织,而骨肉瘤细胞本身则能够进行血管拟态。 总之,这些发现突显了内皮细胞和肿瘤细胞两者显著的可塑性和谱系不忠实性,为内皮细胞在转移性骨肉瘤微环境中的功能作用提供了新的见解,并挑战了目前对骨肉瘤生物学的认识。
查看英文原文 English abstract
Metastatic osteosarcoma is an aggressive malignant bone tumor that primarily affects pediatric, adolescent, and young adult populations and represents an understudied disease with significant unmet medical need. Recent research has increasingly focused on understanding the complex biology of the osteosarcoma microenvironment. While prior studies have primarily examined the roles of macrophages, lymphocytes, and, to a lesser extent, fibroblasts, the tumor vasculature has received comparatively little attention. To address this critical gap, we performed single-nuclei multiome (RNA+ATAC) sequencing on a cohort of 24 human metastatic osteosarcoma specimens. Our data reveal that endothelial cells within the metastatic microenvironment adopt a hybrid transcriptional state indicative of endothelial-to-mesenchymal transition (EndMT). Leveraging our multimodal dataset, joint copy number analysis identified a subset of tumor cells that cluster with endothelial cells, demonstrating that osteosarcoma cells engage in vascular mimicry. Further investigation of gene regulatory networks revealed a subset of endothelial cells undergoing endothelial-to-osteoblastic conversion and confirmed endothelial-specific regulatory programs in the osteosarcoma vascular mimics. Analysis of immunosuppressive gene expression suggests that endothelial cells in metastatic osteosarcoma also function in an immunoregulatory capacity. Both in vitro and in vivo functional assays were employed to validate these findings. Modified transwell co-culture assays demonstrated that osteosarcoma-derived factors induce osteoblastic gene expression programs in lung microvascular endothelial cells. Additionally, using endothelial lineage-tracing mice in combination with GFP + syngeneic murine osteosarcoma cells, we provide in vivo evidence that endothelial cells can be reprogrammed into osteoblast-like cells that integrate into malignant osteoid, while osteosarcoma cells themselves are capable of vascular mimicry. Collectively, these findings highlight the remarkable plasticity and lineage infidelity of both endothelial and tumor cells, provide novel insights into the functional role of endothelial cells in the metastatic osteosarcoma microenvironment, and challenge current understanding of osteosarcoma biology.
利益披露 Disclosure
Y. Wu, None.. J. Burks, None.. D. Williams, None.. C. Sayers, None.. V. Daulatabad, None.. N. Syed, None.. J. F. Shern, None.. T. A. McEachron, None.

← 返回 AACR 2026 检索